These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 11374410
1. Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus. Jain A, Kashyap R, Marsh W, Rohal S, Khanna A, Fung JJ. Transplantation; 2001 Apr 27; 71(8):1102-6. PubMed ID: 11374410 [Abstract] [Full Text] [Related]
2. Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation. Jain A, Mazariegos G, Kashyap R, Marsh W, Khanna A, Iurlano K, Fung J, Reyes J. Pediatr Transplant; 2001 Apr 27; 5(2):93-8. PubMed ID: 11328546 [Abstract] [Full Text] [Related]
3. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study. Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P. Transpl Int; 2001 Dec 27; 14(6):420-8. PubMed ID: 11793040 [Abstract] [Full Text] [Related]
5. Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Chakrabarti P, Wong HY, Scantlebury VP, Jordan ML, Vivas C, Ellis D, Lombardozzi-Lane S, Hakala TR, Fung JJ, Simmons RL, Starzl TE, Shapiro R. Transplantation; 2000 Sep 15; 70(5):760-4. PubMed ID: 11003353 [Abstract] [Full Text] [Related]
6. Weaning of immunosuppression in liver transplant recipients. Mazariegos GV, Reyes J, Marino IR, Demetris AJ, Flynn B, Irish W, McMichael J, Fung JJ, Starzl TE. Transplantation; 1997 Jan 27; 63(2):243-9. PubMed ID: 9020325 [Abstract] [Full Text] [Related]
7. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. Reyes J, Jain A, Mazariegos G, Kashyap R, Green M, Iurlano K, Fung J. Transplantation; 2000 Jun 27; 69(12):2573-80. PubMed ID: 10910279 [Abstract] [Full Text] [Related]
8. Steroid-free immunosuppression during and after liver transplantation--a 3-yr follow-up report. Pirenne J, Aerts R, Koshiba T, Van Gelder F, Roskams T, Schetz M, Verhaegen M, Lauwers P, Fevery J, Nevens F. Clin Transplant; 2003 Jun 27; 17(3):177-82. PubMed ID: 12780665 [Abstract] [Full Text] [Related]
9. Steroid avoidance reduce the cost of morbidities after live-donor renal allotransplants: a prospective, randomized, controlled study. Gheith OA, Nematalla AH, Bakr MA, Refaie A, Shokeir AA, Ghoneim MA. Exp Clin Transplant; 2011 Apr 27; 9(2):121-7. PubMed ID: 21453230 [Abstract] [Full Text] [Related]
18. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients. McKee M, Segev D, Wise B, Case B, Neu A, Fivush B, Colombani P. J Pediatr Surg; 1997 May 27; 32(5):688-90. PubMed ID: 9165452 [Abstract] [Full Text] [Related]
19. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy. Manousou P, Samonakis D, Cholongitas E, Patch D, O'Beirne J, Dhillon AP, Rolles K, McCormick A, Hayes P, Burroughs AK. Liver Transpl; 2009 Dec 27; 15(12):1783-91. PubMed ID: 19938143 [Abstract] [Full Text] [Related]